A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis-Reference-Cited by-同舟云学术

A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis

Published:2017-05-31 Issue:7658 Volume:546 Page:376-380
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Manjunatha Ujjini H.,Vinayak Sumiti,Zambriski Jennifer A.,Chao Alexander T.,Sy Tracy,Noble Christian G.,Bonamy Ghislain M. C.,Kondreddi Ravinder R.,Zou Bin,Gedeck Peter,Brooks Carrie F.,Herbert Gillian T.,Sateriale Adam,Tandel Jayesh,Noh Susan,Lakshminarayana Suresh B.,Lim Siau H.,Goodman Laura B.,Bodenreider Christophe,Feng Gu,Zhang Lijun,Blasco Francesca,Wagner Juergen,Leong F. Joel,Striepen Boris,Diagana Thierry T.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature22337.pdf

Reference35 articles.

1. Liu, L. et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 388, 3027–3035 (2016)

2. Kotloff, K. L. et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382, 209–222 (2013)

3. Platts-Mills, J. A . et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob. Health 3, e564–e575 (2015)

4. Checkley, W. et al. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect. Dis. 15, 85–94 (2015)

5. Amadi, B. et al. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect. Dis. 9, 195 (2009)

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyridopyrimidinones as a new chemotype of calcium dependent protein kinase 1 (CDPK1) inhibitors for Cryptosporidium;Molecular and Biochemical Parasitology;2024-12

2. Emerging therapeutic avenues against Cryptosporidium: A comprehensive review;Veterinary Parasitology;2024-10

3. Cryptosporidium impacts epithelial turnover and is resistant to induced death of the host cell;mBio;2024-08-14

4. Treating cryptosporidiosis: A review on drug discovery strategies;International Journal for Parasitology: Drugs and Drug Resistance;2024-08

5. Pharmacokinetics and tissue distribution of LN002, a new compound alternative oxidase inhibitor against Cryptosporidium in rats;Frontiers in Pharmacology;2024-07-30